The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

30 Jun 2017 11:31

RNS Number : 7489J
Proxama PLC
30 June 2017
 

Neither this announcement nor any part of it constitutes an offer to sell or issue or the solicitation of an offer to buy, subscribe or acquire any securities in any jurisdiction in which any such offer or solicitation would be unlawful and the information contained herein is not for publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any jurisdiction in which such publication or distribution would be unlawful.

 

Proxama Plc

 ("Proxama" or the "Company")

Result of Placing

Directors' Participation

Posting of Circular and Notice of General Meeting

Posting of Annual Report and Accounts

and

Posting of Notice of AGM

 

Other than where otherwise defined, capitalised terms used in this announcement have the meanings given to them in the announcement released earlier today by the Company (the "Placing Announcement").

 

Result of Placing

 

Proxama PLC (AIM: PROX), a leading mobile location and data intelligence expert, is pleased to announce the successful completion of an upsized bookbuild for the Placing that was announced earlier today.

 

The Placing Shares, being 5,000,000,000 New Ordinary Shares, have been placed by Peel Hunt at the Issue Price of 0.03 pence per share, representing a 79.31 per cent. discount to the closing price of 0.145 pence on 29 June 2017 (being the day prior to this announcement) with new and existing investors, raising gross proceeds of approximately £1.5 million (approximately £1.2 million net of expenses).

 

The Placing Shares will represent approximately 207.5 per cent. of the Existing Ordinary Shares and approximately 22.7 per cent. of the Enlarged Share Capital (assuming a full take up of the Open Offer).

 

Open Offer

 

The Company also confirms that Qualifying Shareholders will be given the opportunity to subscribe for New Ordinary Shares through an Open Offer to raise up to approximately £4.1 million, on the basis of 17 Open Offer Shares for every 3 Existing Ordinary Shares held, at the Issue Price.

 

General Meeting

 

The proposed Placing and Open Offer (together the "Fundraising") are subject to the passing of certain resolutions (the "Resolutions") for which Shareholder approval will be sought at the general meeting of the Company, which is expected to be convened by posting today to Shareholders a circular containing notice of the General Meeting. The Circular will set out the reasons for, and provide further information on, the Fundraising, to explain why the Board considers the Fundraising to be in the best interests of the Company and its Shareholders as a whole and why the Directors unanimously recommend that Shareholders vote in favour of the Resolutions.

 

John Kennedy, CEO of Proxama, said:

 

"I would like to thank our existing and new shareholders for the faith they have put in Proxama and look forward to updating shareholders on our progress in the months ahead."

 

Directors' participation

 

Directors, prospective directors and certain shareholders of the Company have, in aggregate, invested £200,000 of the funds raised in the Placing.

The participation of the Directors and prospective directors of the Company in the Placing is set out in the table below:

Date of this document

Participation in the Placing

Immediately following the Proposals

Number of Existing Ordinary Shares

Percentage of issued Existing Ordinary Shares

Number of Placing Shares

Participation (£)

Total Number of Ordinary Shares

Percentage of Enlarged Share Capital

Current, Proposed and Past Directors

Kelvin Harrison

(Non- Executive Chairman)

-

-

66,666,666

£20,000

66,666,666

0.32%

John Kennedy

(Chief Executive Officer)

800,000

0.03%

83,333,333

£25,000

84,133,333

0.40%

Shaun Gregory

(Non-Executive Director)

-

-

166,666,666

£50,000

166,666,666

0.79%

Mark Slade

(Proposed Managing Director)

-

-

100,000,000

£30,000

100,000,000

0.47%

Dan Francis

(Proposed Chief Strategic Officer)

-

-

83,333,333

£25,000

83,333,333

0.40%

David Bailey

(Previous Deputy Chairman)

33,342,125

1.38%

166,666,666

£50,000

200,008,791

0.95%

Total

34,142,125

1.42%

666,666,664

£200,000

700,808,789

3.33%

 

*assuming a full take up under the Open Offer.

Related Party Transaction

The participation by Kelvin Harrison, John Kennedy, Dan Francis, Shaun Gregory, and Mark Slade, in the Placing constitutes a related party transaction for the purposes of the AIM Rules. In the absence of any independent directors in connection with the Placing, the Company's nominated adviser, Peel Hunt, considers that the terms of the related party transactions are fair and reasonable insofar as the Company's shareholders are concerned.

 

Posting of Circular and Notice of General Meeting, Annual Report and Accounts, and Notice of AGM

 

The Company announces that, pursuant to AIM Rule 20, its Annual Report and Accounts for the financial period ended 31 December 2016 and Notice of Annual General Meeting will today be posted to shareholders. The AGM is to be held at Taylor Vinters LLP, Tower 42, 33rd Floor, 25 Old Broad Street, London EC2N 1HQ at 9.00 a.m on 24 July 2017.

 

The Company also confirms that a Circular and related Form of Proxy in relation to the Placing and Open Offer which was announced today will shortly be posted to Shareholders. The Circular contains notice of the General Meeting to be held at Taylor Vinters LLP, Tower 42, 33rd Floor, 25 Old Broad Street, London EC2N 1HQ at 9.15 a.m on 24 July 2017, or as soon as possible following the conclusion of the AGM.

 

Prior to publication, certain information contained within this announcement was deemed to constitute inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon publication of this announcement, this information is now considered to be in the public domain.

Enquiries:

For further Information:

 

Proxama PLC

John Kennedy, Chief Executive

020 3668 2888

 

Peel Hunt LLP

(Nominated Adviser and Broker)

Richard Kauffer

Euan Brown

020 7418 8900

Redleaf Communications

Charlie Geller

Elise Palmer

Sam Modlin

0207 382 4769

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWGUMPQUPMGUU
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.